News

Deal Announcements

Gloucester Pharma Collects $29 Million Venture Capital

Thursday, August 27, 2009 5:30:00 AM PDT | VentureDeal Staff
Cambridge, Massachusetts  --  Pharmaceutical development company Gloucester Pharmaceuticals has secured $29 million in its series D round of institutional venture capital investment.

Gloucester says that it is developing a pipeline of products for the treatment of cancer.

Novo A/S was the lead investor in the round, which also included Apple Tree Partners, ProQuest Investments, Prospect Venture Partners and Rho Ventures.  The company said that the proceeds would be used to continue development of its treatment for T cell lymphomas.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1